Aegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine
Wavelet is on a mission to eliminate preventable brain injury at birth and reduce unnecessary caesarean sections, improving the lives of babies and mothers around the world.
NEW YORK, April 14, 2026 /PRNewswire/ — A breakthrough in fetal brain monitoring developed at Yale is moving from laboratory discovery to global commercialization through a pivotal partnership with Aegis Ventures, including $7M in seed funding.
Wavelet Medical, founded by Liz Golden (CEO), Dr. Emily Lee (Chief Medical Officer), and Dr. Jose Cortes-Briones (Head of Science), has partnered with Aegis Ventures to co-create and scale the first non-invasive, AI-powered fetal electroencephalography (EEG) monitoring platform – technology designed to detect fetal brain distress in real time and prevent avoidable brain injury at birth.
